Stuttgart - Delayed Quote EUR

Astera Labs Inc. (64B.SG)

232.00 -9.00 (-3.73%)

As of 2:16:13 PM GMT+1. Market Open.

Chart Range Bar

Loading chart for 64B.SG

Previous Close 241.00
Open 235.00
Bid 232.00 x --
Ask 234.00 x --
Day's Range 232.00 - 235.00
52 Week Range 232.00 - 235.00
Volume 0
Avg. Volume --
Market Cap (intraday) --
Beta (5Y Monthly) 0.94
PE Ratio (TTM) --
EPS (TTM) --
Earnings Date Nov 3, 2026
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 73.00

PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the prevention and treatment of disease. The company's platforms are used by researchers worldwide, including pharmaceutical companies and comprehensive cancer centers. PhenomeX Inc. is headquartered in Emeryville, California. As of September 29, 2023, PhenomeX Inc. operates as a subsidiary of Bruker Corporation.

phenomex.com

285

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Earnings Per Share

No Earnings Per Share available for this ticker

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY23

Revenue 14.06M

Earnings -50.24M

Profit Margin -357.31%

FY22

FY23

-40M

-20M

20M

-300.0%

-200.0%

-100.0%

0.0%

Analyst Price Targets

61.00 Low

73.00 Average

232.00 Current

100.00

Latest Rating

Date 1/15/2026

Analyst RBC Capital

Rating Action Initiated

Rating Outperform

Price Action Announces

Price Target 225

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

-173.40%
Return on Assets (ttm)

-28.92%
Return on Equity (ttm)

-87.18%
Revenue (ttm)

71.82M
Net Income Avi to Common (ttm)

-124.53M
Diluted EPS (ttm)

--

Balance Sheet and Cash Flow

Total Cash (mrq)

30.96M
Total Debt/Equity (mrq)

26.03%
Levered Free Cash Flow (ttm)

-45.18M

U.S. markets open in 51m

Astera Labs Inc. (64B.SG)

Astera Labs Inc. Overview Biotechnology / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Latest Rating

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports